Seoul Pharma Co., Ltd. operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Seoul Pharma Co., Ltd. with three other
companies in this sector in South Korea:
Aprogen Pharmaceuticals Inc
sales of 45.40 billion Korean Won [US$38.13 million]
of which 1%
Kyung Nam Pharm Company Limited
(41.43 billion Korean Won [US$34.80 million]
Samsung Pharmaceutical Co Ltd
(46.48 billion Korean Won [US$39.05 million]
of which 92%
was Pharmaceuticals Segment).
During the year ended December of 2018, sales at
Seoul Pharma Co., Ltd. were 44.14 billion Korean Won (US$37.08 million).
decrease of 5.4%
versus 2017, when the company's sales were 46.65 billion Korean Won.
The sales level in 2018 was fairly close to the level five years ago: in 2013, Seoul Pharma Co., Ltd. had sales
of 42.04 billion Korean Won.